15:59 Apr 29

Cipla Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
1541.50
-13.60 (-0.87%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Cipla Ltd.

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
1541.50
-13.60 (-0.87%)
15:59 Apr 29
Quality
image/svg+xml

88/100
High Financial Strength

Valuation
image/svg+xml

38/100
Mid Valuation

Technical

55/100
Technically Neutral

Strength

16

Weakness

1

Opportunity

1

Threats

0

15.43 %

ROE %

12.59 %

ROA %

61.78

EPS

331.98

BVPS

15.99 %

Net Profit Margin

Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM 2024
Net Sales
19159.59 21763.34 22753.12 25774.09 26981.17
Operating Expenses +
14907.16 17210.56 17726.15 19483.04 20075
Raw Material
7544.6 9220.29 8348.28 8756.54 8831.12
Increase Decrease in Cost
-192.71 -724.69 -96 63.03 -41.03
Other Manufacturing Expense
0 0 0 640.62 0
Employee Cost
3251.83 3529.91 3830.08 4310.04 4683.96
Miscellaneous Expenses
9619.78 12559.37 11301.11 12784.87 6600.95
Operating Profit
4252.43 4552.78 5026.97 6291.05 6906.17
Other Income
265.99 280.91 475.45 746.57 821.74
Depreciation
1067.66 1051.95 1172.11 1051.02 1086.56
Interest
160.7 106.35 109.54 89.88 65.58
Profit before tax and exceptio..
3290.06 3675.39 4220.77 5896.72 6575.77
Exceptional Items
0 -182.12 -182.42 -194.82 0
PBT
3290.06 3493.27 4038.35 5701.9 6575.77
Provision for Taxation
888.76 933.8 1202.86 1546.59 1575.34
Net Profit
2401.3 2559.47 2835.49 4155.31 5000.43
NET Profit after MI
2404.87 2516.75 2801.91 4121.55 4989.72
EPS
29.79 31.17 34.69 51.01 61.95
Operating Profit Margin (%)
22.19 20.92 22.09 24.41 25.6
Net Profit Margin (%)
12.55 11.56 12.31 15.99 18.49

ShareHolding

All Data in Percentage (%)

Mar 25 Dec 24 Sep 24 Jun 24 Mar 24
Promoter 29.20 29.20 30.90 30.90 33.50
FII 26.30 26.60 28.80 27.80 25.80
MF 20.50 20.50 17.50 17.60 16.80
Public 16.40 16.40 16.10 16.30 16.30
Others 0.00 0.00 0.00 0.00 0.00
Others 7.60 7.30 6.70 7.40 7.60
Shareholder Shares Holding %

Download Our App On: